Featured
  • Cyanobacteria, Michael Faraday, and Insulin – MostlyScience Webcast –  22/04/2018

    Cyanobacteria, Michael Faraday, and Insulin – MostlyScience Webcast – 22/04/2018

    Wes

    In this Episode of MostlyScience, Wes is joined by Dr. Anna of Dr. Anna’s Imaginarium and Holly Blunden of MostlyScience to celebrate science as we pass the anniversary of the March for Science. We share some of our favourite science stories including the magic of Cyanobacteria, the father of electromagnetism Michael Faraday, and the discovery of Insulin, […]

    Full story
  • Science Censorship – MostlyScience Webcast – 14/04/2018

    Science Censorship – MostlyScience Webcast – 14/04/2018

    Wes

    In this Episode of MostlyScience, Wes is joined by Holly Griffith from NASA’s Johnson Space Center as they discuss her google spreadsheet that she has been keeping for over a year tracking science censorship by the Trump administration. We also discuss Scott Pruitt and the EPA, and Why Facts Matter. Host: @WesleyWilson  Guest(s): Holly Griffith @absolutspacegrl You can […]

    Full story
  • Celgene: A Promising Biotech.

    Celgene: A Promising Biotech.

    Christopher_NW

    Recently I interviewed for an investment research position in Edinburgh. For this I had to put a stock pitch together, and so I decided to make a pitch for the North American biotech company Celgene. Below is the pitch I gave and it should be noted that since making the pitch the stock has steadily […]

    Full story
  • The Malaria Thesis, Part 1

    The Malaria Thesis, Part 1

    Christopher_NW

    In February I attained my Ph.D completion letter from the Universities of Melbourne and Edinburgh for my thesis titled ‘Biochemical and Biophysical Investigations Into Key Malaria Parasite Proteins’. I have since decided to turn parts of the thesis into a series of articles on malaria that are accessible to a non-expert. If you want to […]

    Full story
Health
The Reasoning Behind a Debt/EBITDA Ratio Surge and the Healthcare Industry.

The Reasoning Behind a Debt/EBITDA Ratio Surge and the Healthcare Industry.

Christopher_NW

 

  Recently I interviewed at a firm in London for a Healthcare Mergers and Acquisitions (M&A) role and the CEO asked me a question during my presentation where I had mentioned that the company I was analysing had a very low debt/EBITDA ratio which was in contrast to the overall market. He asked why I […]

Back to Top